The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Seizure rates in enzalutamide (ENZ)-treated men with metastatic castration-resistant prostate cancer (mCRPC) at increased risk of seizure: UPWARD study.
 
Susan F. Slovin
Consulting or Advisory Role - Bayer
 
William Clark
Research Funding - Astellas Pharma (Inst); Auxilium (Inst); Bayer (Inst); BMS Brazil (Inst); Johnson & Johnson (Inst); Medivation (Inst); Novartis (Inst)
 
Joan Carles
Honoraria - Bayer; Johnson & Johnson
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; Pfizer
 
Andrew Krivoshik
Employment - Astellas Pharma
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Travel, Accommodations, Expenses - Astellas Pharma
 
Jung Wook Park
Employment - Astellas Pharma
Honoraria - Astellas Pharma
Research Funding - Astellas Pharma
 
Fong Wang
Employment - Medivation
Stock and Other Ownership Interests - Medivation
Research Funding - Medivation
Travel, Accommodations, Expenses - Medivation
 
Daniel George
Honoraria - Acceleron Pharma; Astellas Medivation; Bayer; BMS Brazil; Clovis Oncology; Exelixis; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi; Valeant/Dendreon; Viamet/Innocrin
Research Funding - Acerta Pharma; Astellas Medivation; Bayer; BMS Brazil; Celldex; Exelixis; Genentech; GlaxoSmithKline; Janssen; Millennium; Novartis; Pfizer; Viamet/Innocrin